Home » OHRP: All ‘Unanticipated Problems’ in HHS Clinical Trials Must Be Reported
OHRP: All ‘Unanticipated Problems’ in HHS Clinical Trials Must Be Reported
February 15, 2007
All “unanticipated problems” affecting participants in clinical trials sponsored or supported by the U.S. Department of Health and Human Services must be reported, a new guidance from the Office for Human Research Protections (OHRP) says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor